Natasha Malik

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

Scientific reports

Cell death discovery

Beatson Institute for Cancer Research

University of Glasgow (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Beatson Institute for Cancer Research Oct 01 2019

United Kingdom

Research Associate :: Cancer Sciences

Lighthouse Labs for COVID19 Testing Apr 06 2020 - Aug 16 2020

United Kingdom

Manager and lab set up :: Queen Elizabeth University Hospital

University of Glasgow Apr 08 2019 - Aug 31 2019

United Kingdom

Research Associate :: Institute of Cancer Sciences

Education History

University of Glasgow Oct 01 2015

United Kingdom

PHD :: Institute of Cancer Sciences

University of Glasgow Sep 09 2011 - Jun 10 2015

United Kingdom

BSC :: Life Sciences

Publications

Natasha Malik, Jodie Hay, Hassan N B Almuhanna, Karen M Dunn, Jamie Lees, Jennifer Cassels, Jiatian Li, Rinako Nakagawa, Owen James Sansom, Alison M Michie
mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia. Leukemia (2023)
Ali A Azar, Alison M Michie, Anuradha Tarafdar, Natasha Malik, Geetha K Menon, Kathleen J Till, Nikolina Vlatković, Joseph R Slupsky
A novel transgenic mouse strain expressing PKCβII demonstrates expansion of B1 and marginal zone B cell populations. Scientific reports 10 (1) (2020)
Liren Jiang, Natasha Malik, Pilar Acedo, Joanna Zawacka-Pankau
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells. Cell death discovery 5 (2019)
Natasha Malik, Karen M Dunn, Jennifer Cassels, Jodie Hay, Christopher Estell, Owen James Sansom, Alison M Michie
mTORC1 activity is essential for erythropoiesis and B cell lineage commitment. Scientific reports 9 (1) (2019)